ICI in Combination With Chemotherapy or Anti-angiogenic Agents as Second-Line Orbeyondtreatment for Advanced Non-small Cell Lung Cancer

L. Wu, B. Chen, J. Wang, X. Pu, J. Li,Q. Wang,L. Liu, Y. Xu, L. Xu, Y. Kong,K. Li,F. Xu

JOURNAL OF THORACIC ONCOLOGY(2022)

引用 0|浏览6
暂无评分
关键词
Immune checkpoint inhibitors, chemotherapy, anti-angiogenic agents
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要